SGLT2 Inhibitors and Diabetic Ketoacidosis: What You Need to Know About the Hidden Risk
SGLT2 inhibitors help manage type 2 diabetes but carry a hidden risk: euglycemic diabetic ketoacidosis (euDKA), where blood sugar stays normal while ketones rise dangerously. Learn the symptoms, who’s at risk, and how to stay safe.
Read More